DOI:10.2214/AJR.06.0317
AJR 2006; 186:S431-S433
© American Roentgen Ray Society
Imaging of Hepatocellular Carcinoma: Self-Assessment Module
Michelle M. Bittle1 and
Felix S. Chew1
1 Both authors: Department of Radiology, University of Washington, 4245
Roosevelt Way NE, Box 354755, Seattle, WA 98105-6008.
Received March 2, 2006;
accepted after revision March 2, 2006.
Address correspondence to F. S. Chew.
Abstract
The educational objectives for this self-assessment module on imaging of
hepatocellular carcinoma are for the participant to exercise, self-assess, and
improve his or her understanding of imaging of incidentally discovered liver
masses and to gain familiarity with the clinical entity of hepatocellular
carcinoma and its radiologic appearance.
Keywords: gastrointestinal imaging hepatocellular carcinoma liver
INTRODUCTION
This self-assessment module on hepatocellular carcinoma has an educational
component and a self-assessment component. The educational component consists
of three required articles that the participant should read, and two
recommended articles that may provide the participant with additional
information and perspective. The self-assessment component consists of five
multiple-choice questions with solutions. All of these materials are available
on the ARRS web site
(www.arrs.org).
To claim CME and SAM credit, each participant must enter his or her
responses to the questions online.
EDUCATIONAL OBJECTIVES
By completing this educational activity, the participant will:
- Exercise, self-assess, and improve his or her understanding of the
evaluation and management of an incidentally discovered liver mass.
- Gain familiarity with the imaging features of hepatocellular carcinoma.
- Improve his or her understanding of the use of current imaging technologies
in the evaluation of hepatocellular carcinoma.
REQUIRED READING
(available at
www.arrs.org)
- Bittle MM, Chew FS. Radiological reasoning: incidentally
discovered liver mass. AJR 2006;186
[suppl]:S434-S441[Abstract/Free Full Text]
- Szklaruk J, Silverman PM, Charnsangavej C. Imaging in the
diagnosis, staging, treatment, and surveillance of hepatocellular carcinoma.
AJR 2003;180
:441-454[Free Full Text]
- Kim HJ, Kim AY, Kim TK, et al. Transient hepatic
attenuation differences in focal hepatic lesions: dynamic CT features.
AJR 2005;184
:83-90[Free Full Text]
RECOMMENDED READING
(available at
www.arrs.org)
- Lee KH, O'Malley ME, Haider MA, Hanbidge A. Triple-phase
MDCT of hepatocellular carcinoma. AJR2004
;182
:643-649[Abstract/Free Full Text]
- Mok TSK, Yu SCH, Lee C, et al. False-negative rate of
abdominal sonography for detecting hepatocellular carcinoma in patients with
hepatitis B and elevated serum
-fetoprotein levels.
AJR 2004;183
:453-458[Abstract/Free Full Text]
INSTRUCTIONS
- Complete the required reading.
- Visit
www.arrs.org
and select the Journals/Integrative Imaging link on the left-hand side of the
home page.
- Using your member login, order the online SAM as directed.
- Follow the online instructions for entering your responses to the
self-assessment questions and complete the test by answering the questions
online.
| QUESTION 1
Which liver lesion is most likely to appear as hyperdense or perhaps
even calcified on unenhanced CT?
- Hepatocellular carcinoma.
- Intrahepatic cholangiocarcinoma.
- Metastasis from mucinous gastrointestinal primary tumor.
- Hemangioma.
QUESTION 2
Which of the following is a risk factor for the development of
hepatocellular carcinoma?
- Hepatitis A.
- Alcoholic hepatitis.
- Hormone replacement therapy.
- Low
-fetoprotein level.
QUESTION 3
Which CT feature is characteristic of hepatocellular carcinoma?
- Delayed peripheral enhancement.
- Central scar, sometimes with calcification.
- Fibrosis with capsular retraction.
- Hypodensity on unenhanced CT.
QUESTION 4
Which benign lesion has an appearance on CT that is the most similar to
that of hepatocellular carcinoma?
- Hepatic adenoma.
- Focal nodular hyperplasia.
- Regenerative nodule.
- Hemangioma.
QUESTION 5
What are the typical MRI signal characteristics of hepatocellular
carcinoma?
- High T2 signal and variable (high or low) T1 signal.
- Low T2 signal and low T1 signal.
- Variable (high or low) T2 signal and high T1 signal.
- Variable (high or low) T2 signal and variable (high or low) T1 signal.
|
Solution to Question 1
Hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma,
hemangioma, and most metastases appear on unenhanced CT images as hypodense
lesions [1]. Metastases to the
liver from mucinous primary tumors may calcify and are best seen on unenhanced
CT images; metastases from ovarian, thyroid, renal, lung, and breast primary
tumors may also calcify [1].
Option C is the best response.
Solution to Question 2
Hepatitis B and hepatitis C are implicated in the development of HCC, but
hepatitis A is not. Oral contraceptive use is a risk factor for HCC, but
hormone replacement therapy is not. Other risk factors include
1-antitrypsin deficiency, excessive androgen use,
hemochromatosis, and exposure to aflatoxin or vinyl chloride.
Alpha-fetoprotein levels are typically elevated in HCC, not decreased.
Alcoholic hepatitis is an important risk factor for HCC
[2]. Option B is the
best response.
Solution to Question 3
Delayed peripheral enhancement is characteristic of hemangioma. Central
scar, sometimes with calcification, is found in focal nodular hyperplasia and
in the less common fibrolamellar HCC. Fibrosis with capsular retraction is
characteristic of focal confluent fibrosis. HCC is characteristically
hypodense on unenhanced CT; however, so are many other benign and malignant
focal liver lesions [3].
Option D is the best response.
Solution to Question 4
Focal nodular hyperplasia is usually peripherally located and may have a
pedunculated morphology; characteristically, this lesion has a central scar
that enhances on delayed images. Regenerative nodules, on unenhanced CT, are
isodense to liver unless they are siderotic, in which case they are
hyperdense. HCC is hypodense on unenhanced CT. On contrast-enhanced CT,
hemangiomas of the liver generally have a characteristic discontinuous
peripheral puddling during the arterial phase and centripetal filling during
the portal venous phase that continue after blood pooling; HCC has a variable
appearance during the arterial phase, but washes out during the portal venous
phase. Hepatic adenomas have a variable CT appearance that overlaps with that
of HCC on both unenhanced and contrast-enhanced CT; therefore, these two
lesions usually cannot be differentiated reliably from each other on the basis
of CT appearance [4]. Option
A is the best response.
Solution to Question 5
The MRI appearance of HCC can be quite variable, often related to the
degree of differentiation. The T1 appearance is variable, with 40% having low
signal and 35% having high signal; 90% have increased T2 signal
[5]. Option A is the
best response.
References
- Sica GT, Ji H, Ros PR. CT and MR imaging of hepatic metastases.
AJR 2000; 174:691
-698[Free Full Text]
- Szklaruk J, Silverman PM, Charnsangavej C. Imaging in the
diagnosis, staging, treatment, and surveillance of hepatocellular carcinoma.
AJR 2003; 180:441
-454[Free Full Text]
- Lee KH, O'Malley ME, Haider MA, Hanbidge A. Triple-phase MDCT of
hepatocellular carcinoma. AJR 2004;182
: 643-649[Abstract/Free Full Text]
- Grazioli L, Federle MP, Brancatelli G, Ichikawa T, Olivetti L,
Blachar A. Hepatic adenomas: imaging and pathologic findings.
RadioGraphics 2001;21
: 877-892[Abstract/Free Full Text]
- Murakami T, Hori M, Kim T, Kawata S, Abe H, Nakamura H.
Multidetector row CT and MRI in diagnosing hepatocellular carcinoma.
Intervirology 2004;47
: 209-226[Medline]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Related articles in AJR:
- Radiological Reasoning: Incidentally Discovered Liver Mass
- Michelle M. Bittle and Felix S. Chew
AJR 2006 186: S434-S441.
[Abstract]
[Full Text]